Latest Breaking News On - Product candidate - Page 2 : comparemela.com
ATLANTA, Oct. 04, 2023 (GLOBE NEWSWIRE) Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead late-clinical stage product candidate and innovative diagnostic products, today announced that it will be exhibiting at the annual meeting of the American Society of Reproductive Medicine (ASRM): “The Past, The Present, and The Pipeline”, being held in New Orleans, Lo
New-orleansLouisianaUnited-statesCanadaAmericanChuck-padalaFemasy-femblocFemasy-femaseedDrug-administrationNasdaqAmerican-society-of-reproductive-medicineLifesci-advisors